Short-Term Visiting Fellowship In Crispr Cas Technology In Italy

Prof. Donato Zipeto at the University of Verona, Italy, invites scientists and physician-scientists around the world for a short-term certified fellowship in CRISPR/Cas9 Gene Editing Technology. Please refer your colleagues or interested students. This program is only available through Trialect's seizfire platform. Career Benefits of CRISPR/Cas Technology
Leadership in Genetic Engineering Pharmaceutical Innovation and Collaboration Potential for Groundbreaking Discoveries Career Advancement in Pharma: Amgen, Novartis, Gilead Sciences, Merck, and Pfizer are all active in this area. Feedback
The training period, 2 weeks, was too short to accommodate all its components. It was a live, hands-on experience, and the group members in the hosting Lab helped me during the hands-on training. They were dedicated and willingly transferred all their skills to me within a limited period. Thanks a lot to the group.
#J-18808-Ljbffr